Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.74 USD | +4.18% | +6.88% | +3.72% |
10/05 | Edesa Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 | CI |
05/03 | Top Premarket Gainers | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.72% | 15.24M | |
+9.58% | 115B | |
+12.41% | 107B | |
-2.59% | 21.6B | |
-12.38% | 22.31B | |
-5.29% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B |
- Stock Market
- Equities
- EDSA Stock
- News Edesa Biotech, Inc.
- Edesa Biotech, US FDA Agree on EB05 Phase 3 Trial's Primary Endpoint, Population